Adaptive Biotechnologies (ADPT) Inventory (2018 - 2026)

Adaptive Biotechnologies has disclosed Inventory across 9 years of filings, most recently posting $10.5 million for Q2 2026.

• In Q2 2026, Inventory rose 24.92% year-over-year to $10.5 million; the TTM figure through Jun 2026 stood at $10.5 million (up 24.92% YoY), while the FY2025 annual figure was $9.8 million, up 16.35% from the prior year.
• Inventory came in at $10.5 million for Q2 2026 at Adaptive Biotechnologies, down from $11.2 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $21.0 million in Q1 2022 to a low of $8.4 million in Q2 2025.
• Average Inventory over 5 years is $13.9 million, with a median of $13.3 million recorded in 2024.
• Year-over-year, Inventory plunged 41.58% in 2024 and increased 29.04% in 2026.
• Over 5 years, Inventory stood at $14.5 million in 2022, then slipped by 0.03% to $14.4 million in 2023, then slumped by 41.58% to $8.4 million in 2024, then increased by 16.35% to $9.8 million in 2025, then rose by 6.89% to $10.5 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $10.5 million in Q2 2026, $11.2 million in Q1 2026, and $9.8 million in Q4 2025.